Keith C. Blackmon

Keith C. Blackmon serves as a key procurement professional within the W40M MRC0 West agency of the Department of the Army, supporting the mission of ensuring operational medical readiness through the acquisition of advanced diagnostic, therapeutic, and laboratory systems. He manages a portfolio of contracts focused on in-vitro diagnostic substances, surgical instrumentation, sterilization equipment, and blood management technologies essential for field-deployable, high-acuity medical care. His work directly enables the Army’s medical sovereignty by securing mission-critical capabilities that sustain combat medics and forward surgical teams in austere environments. Blackmon maintains consistent partnerships with leading medical technology vendors including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These relationships reflect a preference for established industry leaders with proven capabilities in FDA-regulated, military-specification medical devices and laboratory systems. His contracting approach emphasizes technical rigor, compliance with defense acquisition regulations, and long-term sustainment support for complex medical platforms. His procurement patterns show a balanced approach to socioeconomic set-asides, with approximately one-third of awards designated as total small business set-asides under FAR 19.5, indicating a deliberate effort to integrate capable small businesses into the medical supply chain. While the majority of acquisitions remain open to all competitors, his portfolio actively supports small business participation without compromising mission-critical performance standards. Blackmon’s primary NAICS focus areas include analytical laboratory instrument manufacturing, in-vitro diagnostic substance production, and general medical and surgical hospital services, reflecting deep expertise in clinical diagnostics and procedural support systems. He routinely procures precision medical instruments, automated testing platforms, and sterilization infrastructure, demonstrating specialized knowledge in the intersection of clinical medicine, regulatory compliance, and defense logistics.